Cargando…
A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive Candidiasis
BACKGROUND: Amphotericin B deoxycholate (AmB-D) is standard of care treatment for neonatal invasive candidiasis (IC). Micafungin (MCA) has broad-spectrum fungicidal activity against Candida spp. We compared the efficacy and safety of intravenous MCA with intravenous AmB-D and assessed the pharmacoki...
Autores principales: | Benjamin, Daniel K., Kaufman, David A., Hope, William W., Smith, P. Brian, Arrieta, Antonio, Manzoni, Paolo, Kovanda, Laura L., Lademacher, Christopher, Isaacson, Brigit, Jednachowski, Deborah, Wu, Chunzhang, Kaibara, Atsunori, Walsh, Thomas J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155365/ https://www.ncbi.nlm.nih.gov/pubmed/29596222 http://dx.doi.org/10.1097/INF.0000000000001996 |
Ejemplares similares
-
Micafungin in Premature and Non-premature Infants: A Systematic Review of 9 Clinical Trials
por: Manzoni, Paolo, et al.
Publicado: (2014) -
Exposure–Response Analysis of Micafungin in Neonatal Candidiasis: Pooled Analysis of Two Clinical Trials
por: Kovanda, Laura L., et al.
Publicado: (2018) -
In vitro activities of amphotericin B deoxycholate and liposomal amphotericin B against 604 clinical yeast isolates
por: Montagna, Maria Teresa, et al.
Publicado: (2014) -
Safety, Efficacy and Pharmacokinetics of Anidulafungin in Patients 1 Month to <2 Years of Age With Invasive Candidiasis, Including Candidemia
por: Roilides, Emmanuel, et al.
Publicado: (2020) -
Micafungin in the treatment of invasive candidiasis and invasive aspergillosis
por: Wiederhold, Nathan P, et al.
Publicado: (2009)